Gene · 57007
Papers3,960
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,960
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A prognostic mathematical model based on tumor microenvironment-related genes expression for breast cancer patients. | Front Oncol | 2023 | 37860187 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals molecular signature and cell-type difference of Homo sapiens endothelial-to-mesenchymal transition. | G3 (Bethesda) | 2023 | 37857450 | PubTator, text mining | PubMed |
| Regulating Chemokine-Receptor Interactions through the Site-Specific Bioorthogonal Conjugation of Photoresponsive DNA Strands. | Bioconjug Chem | 2023 | 37856672 | PubTator, text mining | PubMed |
| Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras. | Science | 2023 | 37856615 | PubTator, text mining | PubMed |
| Higher Plasma Stromal Cell-Derived Factor 1 Is Associated with Lower Risk for Sarcopenia in Older Asian Adults. | Endocrinol Metab (Seoul) | 2023 | 37849050 | PubTator, text mining | PubMed |
| [Regulatory Mechanism of Mangiferin Combined with Bortezomib on Malignant Biological Behavior of Burkitt Lymphoma and Its Effect on Expression of CXC Chemokine Receptors]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2023 | 37846690 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms. | J Bone Oncol | 2023 | 37842554 | PubTator, text mining | PubMed |
| Editorial: New insights into molecular mechanisms and targeted therapy for gastrointestinal tumors. | Front Cell Dev Biol | 2023 | 37842088 | PubTator, text mining | PubMed |
| Molecular Evidence of Breast Cancer Cell Proliferation Inhibition by a Combination of Selected Qatari Medicinal Plants Crude Extracts. | Nutrients | 2023 | 37836560 | PubTator, text mining | PubMed |
| Predictive Potential of Biomarkers of Intestinal Barrier Function for Therapeutic Management with Teduglutide in Patients with Short Bowel Syndrome. | Nutrients | 2023 | 37836505 | PubTator, text mining | PubMed |
| Keras/TensorFlow in Drug Design for Immunity Disorders. | Int J Mol Sci | 2023 | 37834457 | PubTator, text mining | PubMed |
| Targeting the Cancer-Neuronal Crosstalk in the Pancreatic Cancer Microenvironment. | Int J Mol Sci | 2023 | 37834436 | PubTator, text mining | PubMed |
| Prognostic significance of plasma SDF-1 in acute ischemic stroke patients with diabetes mellitus: the CATIS trial. | Cardiovasc Diabetol | 2023 | 37817149 | PubTator, text mining | PubMed |
| CXCR7 promotes the migration of fibroblasts derived from patients with acquired laryngotracheal stenosis by NF-κB signaling. | Transl Pediatr | 2023 | 37814711 | PubTator, text mining | PubMed |
| IL-33 priming and antigenic stimulation synergistically promote the transcription of proinflammatory cytokine and chemokine genes in human skin mast cells. | BMC Genomics | 2023 | 37798647 | PubTator, text mining | PubMed |
| The role of angiogenic growth factors in the immune microenvironment of glioma. | Front Oncol | 2023 | 37790751 | PubTator, text mining | PubMed |
| Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. | Mol Cancer | 2023 | 37784082 | PubTator, text mining | PubMed |
| Interneuron odyssey: molecular mechanisms of tangential migration. | Front Neural Circuits | 2023 | 37779671 | PubTator, text mining | PubMed |
| Subarachnoid hemorrhage alters CX43 and ACKR3 levels in cerebrospinal fluid: A preclinical study. | Asian J Surg | 2023 | 37777402 | PubTator, text mining | PubMed |
| The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy. | Front Immunol | 2023 | 37771579 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57007/papers?page=16